Rob Michael, AbbVie CEO
AbbVie executives bask in Skyrizi, Rinvoq successes as the drugs take up Humira's mantle
The reports of AbbVie’s demise have been greatly exaggerated.
Gone are the worries of Humira competition and its monumental patent cliff. The “
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
